MERIT MEDICAL SYSTEMS INC (MMSI) Q3 2025 10-Q Quarterly Report
Filed: Oct 30, 2025Period ending Sep 30, 2025
Health Care
Surgical & Medical Instruments & ApparatusSEC EDGAR MERIT MEDICAL SYSTEMS INC (MMSI) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Oct 30, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
MERIT MEDICAL SYSTEMS INC Q3 2025 10-Q Analysis
Management Discussion & Analysis
- • Revenue and YoY change not disclosed in provided text
- • Profitability or margin figures not provided
Risk Factors
- • New leadership transition risk triggered by CEO Fred Lampropoulos resignation and Martha Aronson appointment effective October 3, 2025
- • Most material update: increased labor cost risk in Mexico due to inflationary pressures and labor shortages impacting talent retention
MERIT MEDICAL SYSTEMS INC Q3 2025 Quarterly FinancialsXBRL
Revenue
$384M
▲ +13.0% YoY▲ +0.4% QoQ
Net Income
$28M
▼ -2.4% YoY▼ -14.8% QoQ
Gross Margin
48.5%
▲ +217bp YoY▲ +29bp QoQ
Operating Margin
11.1%
▲ +13bp YoY▼ -117bp QoQ
Net Margin
7.2%
▼ -114bp YoY▼ -129bp QoQ
ROE
1.8%
Total Assets
$2.6B
EPS (Diluted)
$0.46
▼ -4.2% YoY▼ -14.8% QoQ
Operating Cash Flow
$75M
▲ +58.4% YoY▼ -10.0% QoQ
Source: XBRL data from MERIT MEDICAL SYSTEMS INC Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.
Get deeper insights on MERIT MEDICAL SYSTEMS INC
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.